Back to top
more

Nature's Sunshine Products (NATR)

(Real Time Quote from BATS)

$19.51 USD

19.51
21,972

-0.28 (-1.42%)

Updated Apr 30, 2024 03:36 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 37% (94 out of 251)

Industry: Medical - Drugs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for NATR

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

 

Fiscal Year End for Nature's Sunshine Products, Inc falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 82 60 86 92 54
Receivables 9 14 9 7 7
Notes Receivable 0 0 0 0 0
Inventories 67 68 61 48 47
Other Current Assets 8 7 9 7 5
Total Current Assets 166 150 165 154 113
Net Property & Equipment 45 46 51 54 60
Investments & Advances 1 1 1 1 1
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 15 7 14 9 5
Intangibles 0 0 0 0 1
Deposits & Other Assets 10 10 10 11 10
Total Assets 250 230 259 250 213
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 0 0 0 1 2
Accounts Payable 8 6 10 6 4
Current Portion Long-Term Debt 0 1 1 1 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 56 47 55 51 44
Income Taxes Payable 6 4 3 2 1
Other Current Liabilities 2 2 4 2 1
Total Current Liabilities 77 66 77 70 58
Mortgages 0 0 0 0 0
Deferred Taxes/Income 2 2 3 2 3
Convertible Debt 0 0 0 0 0
Long-Term Debt 0 0 1 2 0
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 1 1 1 1 3
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 90 83 97 92 84
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 120 122 133 139 136
Capital Surplus 0 0 0 0 0
Retained Earnings 50 35 35 26 5
Other Equity -10 -9 -7 -8 -11
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 160 147 161 157 129
Total Liabilities & Shareholder's Equity 250 230 259 250 213
Total Common Equity 160 147 161 157 129
Shares Outstanding 19.00 19.10 19.70 19.60 19.30
Book Value Per Share 8.40 7.70 8.19 8.02 6.71

Fiscal Year End for Nature's Sunshine Products, Inc falls in the month of December.

All items in Millions except Per Share data.

3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Assets          
Cash & Equivalents -99,999 82 76 69 66
Receivables NA 9 9 12 10
Notes Receivable NA 0 0 0 0
Inventories NA 67 66 66 68
Other Current Assets NA 8 8 9 11
Total Current Assets NA 166 160 156 154
Net Property & Equipment NA 45 46 45 46
Investments & Advances NA 1 1 1 1
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 15 10 9 7
Intangibles NA 0 0 0 0
Deposits & Other Assets NA 10 9 10 10
Total Assets NA 250 240 236 235
Liabilities & Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Notes Payable NA 0 0 1 1
Accounts Payable NA 8 7 7 9
Current Portion Long-Term Debt NA 0 0 0 0
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 56 55 53 51
Income Taxes Payable NA 6 5 4 5
Other Current Liabilities NA 2 1 1 1
Total Current Liabilities NA 77 73 71 72
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 2 2 2 2
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 0 0 0 0
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 1 1 1
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 90 88 87 88
Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 120 123 123 122
Capital Surplus NA 0 0 0 0
Retained Earnings NA 50 41 38 36
Other Equity NA -10 -12 -11 -10
Treasury Stock NA 0 0 0 0
Total Shareholder's Equity NA 160 152 149 147
Total Liabilities & Shareholder's Equity NA 250 240 236 235
Total Common Equity 0 160 152 149 147
Shares Outstanding 18.80 19.00 19.00 19.10 19.00
Book Value Per Share 0.00 8.40 8.00 7.82 7.72